Literature DB >> 16534247

Cathepsin B activates human trypsinogen 1 but not proelastase 2 or procarboxypeptidase B.

Björn Lindkvist1, Ignacio Fajardo, Gunnar Pejler, Anders Borgström.   

Abstract

BACKGROUND/AIMS: Activation of trypsinogen to trypsin is a crucial step in the development of acute pancreatitis. The cause of this activation is not known although suggested explanations include autoactivation, cathepsin B-mediated activation and activation by mast cell tryptase. The aim of this study was to investigate cathepsin B and tryptase activation of pancreatic zymogens.
METHODS: Trypsinogen-1, proelastase, and procarboxypeptidase B were purified from human pancreatic juice. Human cathepsin B and betaI-tryptase are commercial products. Activation and degradation of zymogens were measured by activity towards specific substrates for trypsin and pancreatic elastase, ELISAs for procarboxypeptidase B and its activation peptide, and a radioimmunoassay for the trypsinogen activation peptide.
RESULTS: Cathepsin B caused activation of trypsinogen-1 with a trypsin yield of about 30% of that produced by enterokinase. Proelastase and procarboxypeptidase B was not activated by cathepsin B. None of the zymogens were inactivated by cathepsin B. Neither monomeric nor tetrameric tryptase could activate any of the examined zymogens.
CONCLUSION: Cathepsin B is a competent activator of trypsinogen-1, although not as efficient as enterokinase. If cathepsin B is to play a role in protease activation in acute pancreatitis, this most probably occurs by activation of trypsinogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534247     DOI: 10.1159/000091961

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  4 in total

Review 1.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

2.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

3.  Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.

Authors:  Janja Završnik; Miha Butinar; Mojca Trstenjak Prebanda; Aleksander Krajnc; Robert Vidmar; Marko Fonović; Anders Grubb; Vito Turk; Boris Turk; Olga Vasiljeva
Journal:  Oncotarget       Date:  2017-04-24

4.  Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B.

Authors:  Alexandra Demcsák; Andrea Geisz; Miklós Sahin-Tóth
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.